Wenbin Qian

24PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersArtificial life and complex adaptive systemsRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 08, 2026
Integrated Genomic and Tumor Microenvironment Subtyping Improved Risk Stratification in Primary Central Nervous System Lymphoma.

|Sep 08, 2025
CD33<sup>KO</sup>-CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia.

Yao Wang, Xiujuan Zheng, Zhiqian Wang

|Aug 15, 2025
STRaM: A genetic framework for improved cell product provenance for research and clinical translations.

Binglin Li, Chi Le, Wen Lei

|Jul 03, 2025
Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial.

Wen Lei, Hui Liu, Wenhai Deng

|Apr 18, 2025
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial.

Wen Lei, Hui Liu, Wenhai Deng

|Feb 22, 2025
A novel BaEVRless-LV packaging system for the production of lentiviral vectors for clinical-grade CAR-NK cell manufacturing.

Yinyin Zhang, Minghuan Zhang, Mengyuan Li

Pageof 4

Frequent Collaborators

5 joint publications

Wenhai Deng

3 joint publications

Aibin Liang

3 joint publications

Hui Liu

2 joint publications

Yang Xu